OCULAR IMMUNOLOGY AND INFLAMMATION
Scope & Guideline
Connecting research and practice in ocular inflammation.
Introduction
Aims and Scopes
- Ocular Inflammatory Diseases:
The journal focuses on various ocular inflammatory diseases, particularly uveitis, scleritis, and related conditions, examining their etiology, clinical features, and management strategies. - Immune Response Mechanisms:
Research articles explore the immunological mechanisms underlying ocular inflammation, including the roles of cytokines, autoantibodies, and genetic predispositions. - Innovative Therapeutics:
The journal promotes research on new therapeutic approaches, including biologics and immunomodulatory therapies, aimed at improving patient outcomes in ocular inflammatory diseases. - Diagnostic Advances:
A significant emphasis is placed on advancements in diagnostic techniques, such as optical coherence tomography (OCT) and angiography, to enhance the detection and monitoring of ocular inflammation. - Epidemiological Studies:
The journal includes studies investigating the epidemiology and demographic trends associated with ocular inflammatory conditions, providing insights into prevalence and risk factors.
Trending and Emerging
- Impact of COVID-19 on Ocular Health:
The COVID-19 pandemic has spurred a significant increase in studies examining its effects on ocular health, including post-vaccination inflammatory responses and ocular manifestations of the virus. - Role of Artificial Intelligence in Diagnosis:
There is a rising interest in the application of artificial intelligence and machine learning for diagnosing and managing ocular inflammatory diseases, indicating a shift towards technology-driven approaches. - Microbiome and Ocular Inflammation:
Research exploring the relationship between the ocular microbiome and inflammatory diseases is gaining momentum, with studies investigating how microbial profiles influence disease onset and progression. - Personalized Medicine Approaches:
There is an increasing focus on personalized medicine in treating ocular inflammatory conditions, with research aimed at tailoring therapies based on individual patient profiles and responses. - Long-term Outcomes and Quality of Life:
Emerging research is placing greater emphasis on long-term outcomes and quality of life assessments in patients with ocular inflammatory diseases, highlighting the importance of holistic care.
Declining or Waning
- Traditional Pharmacotherapy:
There is a noticeable decrease in studies focusing solely on traditional pharmacotherapy for ocular inflammation, as newer biologic therapies gain prominence. - Invasive Diagnostic Procedures:
Research focusing on invasive diagnostic techniques, such as anterior chamber paracentesis or vitrectomy solely for diagnostic purposes, is becoming less common as non-invasive imaging modalities advance. - Single-Cause Inflammatory Theories:
The trend towards attributing ocular inflammation to single pathogens or causes is declining, with a growing recognition of multifactorial and autoimmune contributions.
Similar Journals
Asia-Pacific Journal of Ophthalmology
Elevating ophthalmic knowledge across the Asia-Pacific region.Asia-Pacific Journal of Ophthalmology is a distinguished open access journal published by the Asia-Pacific Academy of Ophthalmology (APAO), specializing in the latest advancements and research in ophthalmology. Since its inception in 2013, this journal has established itself as a vital platform for disseminating innovative findings and clinical practices across the Asia-Pacific region and beyond. With an impressive Scopus ranking of #10 out of 137 in the field of Medicine (Ophthalmology), placing it in the 93rd percentile, it garners significant attention and respect within the academic community. Currently holding a Q1 categorization in both Medicine (miscellaneous) and Ophthalmology, the journal embraces a broad scope that encompasses clinical studies, experimental research, and reviews aimed at enhancing the understanding and management of eye health. Its open access model since 2019 ensures that all published works are freely accessible, promoting greater collaboration and knowledge sharing among researchers, clinicians, and students. Situated in the Netherlands with a prominent address in Hong Kong, the journal serves as an essential resource for anyone dedicated to the field of ophthalmology.
Ocular Oncology and Pathology
Exploring Ocular Malignancies with PrecisionOcular Oncology and Pathology is a distinguished journal dedicated to the multifaceted study of ocular diseases, particularly focusing on oncology and pathology. Published by KARGER, a reputable publisher based in Switzerland, this journal serves as a vital resource for researchers, clinicians, and students in the fields of ophthalmology, pathology, and oncology. With an ISSN of 2296-4681 and an E-ISSN of 2296-4657, the journal has established itself as a significant contributor to the literature, achieving a commendable ranking of 55th out of 139 in the General Nursing category within Scopus, placing it in the 60th percentile. Now converging its expertise until 2024, Ocular Oncology and Pathology aims to publish high-quality, peer-reviewed research articles that advance the understanding of ocular neoplasms and their pathological features. The journal’s commitment to open access promotes the dissemination of vital scientific knowledge, ensuring worldwide accessibility to high-impact research, making it an essential platform for the academic community.
International Journal of Ophthalmology
Elevating Ophthalmic Science for a Brighter FutureThe International Journal of Ophthalmology, with ISSN 2222-3959 and E-ISSN 2227-4898, is a premier open-access publication dedicated to advancing the field of ophthalmology. Published by IJO PRESS in China, this journal has been a valuable resource since its inception in 2005, providing a platform for groundbreaking research and clinical studies in ophthalmic science. With an impressive Q2 ranking in the 2023 Ophthalmology category and a Scopus rank of #65 out of 137, the journal consistently showcases high-quality articles that contribute significantly to the understanding and treatment of eye diseases. Since adopting an open-access model in 2010, it has expanded its reach, allowing researchers, professionals, and students worldwide to access vital knowledge in the field. The journal aims to bridge the gap between laboratory research and clinical practice, making it an essential resource for those committed to improving visual health and advancing ophthalmologic education and innovation.
Journal of Ophthalmic Inflammation and Infection
Transforming insights into impactful clinical practices.The Journal of Ophthalmic Inflammation and Infection, published by SPRINGER since 2011, stands as a pivotal resource for professionals in the fields of ophthalmology and infectious diseases. With an impactful Q2 ranking in both categories as of 2023, this open access journal is dedicated to disseminating high-quality research and reviews related to ocular inflammation and its infectious causes, fostering a deeper understanding of these critical health issues. The journal is well-regarded in the academic community, currently positioned at Rank #43 in Ophthalmology, reflecting its significance and influence within the discipline. The journal is accessible globally from its base in Germany, offering valuable insights to researchers, healthcare professionals, and students alike. With a commitment to excellence in publishing through 2024 and beyond, this journal continues to contribute meaningfully to innovative studies and clinical practices in ocular health.
Therapeutic Advances in Ophthalmology
Elevating ophthalmology with cutting-edge discoveries.Therapeutic Advances in Ophthalmology is a leading open-access journal published by SAGE Publications Ltd, dedicated to advancing the understanding and treatment of ocular diseases. Since its inception in 2018, this journal has swiftly gained prominence within the ophthalmology community, proudly holding a Q1 designation in the 2023 category quartiles and ranking 34 out of 137 in the Scopus Medicine_Ophthalmology category, placing it in the top 75th percentile. By providing a platform for innovative research, clinical advancements, and educational resources, Therapeutic Advances in Ophthalmology serves as an essential resource for researchers, healthcare professionals, and students in the field. With a commitment to disseminating high-quality research accessible to all, this journal plays a critical role in shaping the future of ophthalmic care and treatment, enabling professionals to stay abreast of the latest developments and best practices in the discipline.
EXPERIMENTAL EYE RESEARCH
Illuminating the Path of Ophthalmology and NeuroscienceEXPERIMENTAL EYE RESEARCH, published by Academic Press Ltd - Elsevier Science Ltd, is a preeminent journal dedicated to advancing the fields of ophthalmology and neuroscience. With a history of insightful publications dating back to 1961, this journal serves as a critical platform for researchers, professionals, and students interested in the cellular and molecular mechanisms underlying visual processes. The journal boasts impressive rankings, including being placed in the top quartile (Q1) of both the Ophthalmology and Sensory Systems categories, and is recognized in the 2nd quartile (Q2) for Cellular and Molecular Neuroscience. With an impact factor reflecting its significant contribution to the field, EXPERIMENTAL EYE RESEARCH is a valuable resource that promotes the exchange of innovative research and ideas essential for understanding the complexities of eye function and vision-related disorders. Researchers looking to publish their findings or stay abreast of the latest studies will find this journal a vital component of their academic toolkit.
BMC Ophthalmology
Advancing Vision Science for a Brighter TomorrowBMC Ophthalmology is a premier open access journal dedicated to advancing the field of ophthalmology through the publication of high-quality, peer-reviewed research. Published by BMC in the United Kingdom, this journal has been a vital resource since its inception in 2001 and continuously contributes to the global dialogue in vision science. With an impact factor reflecting its growing influence, BMC Ophthalmology is ranked among the top quartiles (Q2) in both general medicine and ophthalmology, emphasizing its significance in medical research. The journal encourages submissions that explore innovative diagnostics, treatment approaches, and understandings of various ocular diseases, thereby appealing to researchers, clinicians, and students alike. As an open access platform, it ensures that cutting-edge research is not only published but also readily accessible to a worldwide audience, promoting further study and collaboration in this essential area of medicine.
Turk Oftalmoloji Dergisi-Turkish Journal of Ophthalmology
Connecting Research and Clinical Practice in OphthalmologyTurk Oftalmoloji Dergisi - Turkish Journal of Ophthalmology is a premier peer-reviewed publication dedicated to the field of ophthalmology, published by GALENOS PUBL HOUSE. Since its inception in 1997, this Open Access journal has championed the dissemination of high-quality research, fostering an inclusive environment for sharing knowledge and advancements in eye health. With an ISSN of 1300-0659 and an E-ISSN of 2147-2661, the journal serves as a vital resource for researchers, clinicians, and students interested in the latest findings and innovations in ophthalmic sciences. Although its coverage in Scopus has been discontinued since 2017, the journal has garnered a significant rank of 80 out of 114 in the field of Medicine – Ophthalmology, highlighting its relevance and impact within the discipline. Operating out of Istanbul, Turkey, the Turkish Journal of Ophthalmology continues to be a crucial platform for ophthalmologists and researchers to publish their work and advance the understanding of ocular health.
Journal of Ophthalmic & Vision Research
Exploring Innovations in Eye HealthThe Journal of Ophthalmic & Vision Research, published by KNOWLEDGE E, stands as a crucial platform for disseminating high-quality research in the field of ophthalmology. With an ISSN of 2008-2010 and an E-ISSN of 2008-322X, this journal fosters open access to valuable insights since 2010, enhancing visibility and reach for researchers globally. Based in Dubai, UAE, it has established a reputation for excellence, reflected in its Q2 ranking in Ophthalmology for 2023 and its position among the top 65th percentile in Scopus. Covering a broad spectrum of topics within ophthalmic science, the journal serves as a vital resource for professionals, researchers, and students by presenting original research, reviews, and case studies that drive innovation and collaboration within the community. As the journal continues to contribute to advancements in eye care and vision sciences, it invites scholars to explore, engage, and publish within its pages, thus enriching the global discourse on ophthalmic health.
Journal of Optometry
Enhancing clinical practices with groundbreaking findings.The Journal of Optometry, published by Elsevier, is a leading open access journal dedicated to advancing the field of optometry and vision science. With an ISSN of 1888-4296 and an E-ISSN of 1989-1342, this journal serves as a pivotal platform for researchers, practitioners, and academics alike to disseminate and engage with high-quality original research and review articles. As of 2023, the journal holds an impressive Q2 ranking in the Optometry category, demonstrating its influence and relevance, particularly as it ranks #2 out of 12 in the Health Professions - Optometry category on Scopus with an 87th percentile. Since becoming open access in 2008, the Journal of Optometry has prioritized accessibility and the exchange of ideas, enriching the scholarly community and enhancing practical application in clinical settings. The journal welcomes submissions that push the boundaries of ocular research, clinical practices, and the education of optometry professionals, making it an essential resource for anyone invested in the future of eye health.